🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Asasantin®

Found 11 matching trials

Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients

PHASE4

The primary objective of this study is to assess whether adding modified-re...

Status

Completed

Location

9.169.01 Dept of Clinical Pharmacology

Start Date

2004-04-01

Trial ID

NCT00129038

Treatments Being Tested

modified-release dipyridamole/aspirin aspirin

Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers

PHASE1

Study to investigate whether psychomotor performance which is necessary for...

Status

Completed

Location

Multiple Locations

Start Date

1999-08

Trial ID

NCT02278302

Treatments Being Tested

Aggrenox®Placebo Ethanol

Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers

PHASE1

The objective of the current study is to investigate if a drug-drug interac...

Status

Completed

Location

9.197.001 Boehringer Ingelheim Investigational Site

Start Date

2011-03

Trial ID

NCT01303445

Treatments Being Tested

Aggrenox alone Aggrenox and omeprazole Aggrenox and omeprazole Omeprazole alone

Headache Study to Compare Aggrenox Full Dose and Reduced Dose

PHASE3

Tolerability of a four weeks treatment with Aggrenox® modified release caps...

Status

Completed

Location

Chang Gung Memorial Hospital

Start Date

2002-09

Trial ID

NCT00274586

Treatments Being Tested

Aggrenox® modified release capsules Aggrenox® modified release capsules matching placebo

Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers

PHASE1

To compare the combination of acetylsalicylic acid (25 mg) + modified-relea...

Status

Completed

Location

Multiple Locations

Start Date

2000-01

Trial ID

NCT02268773

Treatments Being Tested

Asasantin®Acetylsalicylic acid low dose Acetylsalicylic acid high dose

Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers

PHASE1

Study to establish the bioequivalence of a new formulation of Asasantin ER ...

Status

Completed

Location

Multiple Locations

Start Date

2004-01

Trial ID

NCT02273531

Treatments Being Tested

Asasantin ER, new formulation Asasantin ER, present commercial formulation

Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH

PHASE4

Comparison of pharmacokinetics of dipyridamole administered as Aggrenox ver...

Status

Completed

Location

Multiple Locations

Start Date

2000-10

Trial ID

NCT02251184

Treatments Being Tested

Aggrenox Dipyridamole Aspirin Lansoprazole

Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects

PHASE1

To investigate the relative bioavailability of telmisartan respectively of ...

Status

Completed

Location

Multiple Locations

Start Date

2004-05

Trial ID

NCT02262793

Treatments Being Tested

telmisartan ASA/ER-DP

Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers

PHASE1

Study to investigate pharmacokinetics, pharmacodynamics and safety of RAD-S...

Status

Completed

Location

Multiple Locations

Start Date

1999-07

Trial ID

NCT02273479

Treatments Being Tested

Asasantin®Placebo

Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male Subjects

PHASE1

The objective of this study was to compare the pharmacokinetics of dipyrida...

Status

Completed

Location

Multiple Locations

Start Date

2003-01

Trial ID

NCT02273557

Treatments Being Tested

Asasantin ER (new formulation I - low)Asasantin ER (new formulation III - medium)Asasantin ER (new formulation II - high)Asasantin ER (present commercial formulation)

Previous Next